Anti-CD4 antibodies
US7541443B2 · kind B2 · utility
0Cited by
2References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 29, 2003 |
| Grant date | Jun 2, 2009 |
| Priority date | — |
| Expiry date | Sep 25, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/71
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inducing tolerance in a primate by use of a compound, or a combination of at least two compounds, that has certain characteristics when tested in vitro. The compound, alone or in combination, is preferably TRX1 antibody and the compound or combination is preferably used in accordance with a specified dosing regimen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.